GOOGL
64
-2
IRM
60
-3
KMB
50
-3
HCP
78
16
PSA
33
-8
FLR
55
2
IPG
50
-3
DOV
76
7
HSY
41
-2
INTC
40
4
EQIX
62
-3
TJX
53
2
TXN
36
-12
CRM
44
-3
NOV
55
-3
TGNA
42
-3
MCO
70
-3
TGT
59
-3
EL
46
-6
STX
45
3
GOOGL
64
-2
IRM
60
-3
KMB
50
-3
HCP
78
16
PSA
33
-8
FLR
55
2
IPG
50
-3
DOV
76
7
HSY
41
-2
INTC
40
4
EQIX
62
-3
TJX
53
2
TXN
36
-12
CRM
44
-3
NOV
55
-3
TGNA
42
-3
MCO
70
-3
TGT
59
-3
EL
46
-6
STX
45
3
Financhill
Back

Titan Pharmaceuticals Quote, Financials, Valuation and Earnings

Master the Market: The Formula for a 96.3% Win Rate Revealed!

Act now!
Sell
39

TTNP
Titan Pharmaceuticals

Last Price:
7.09
Seasonality Move:
90.71%

7 Day Trial

ALL ACCESS PASS

$ 7

This DeFi Coin Could 10x Soon... I Advise You Get In Now!

Discover this DeFi diamond before the next surge

Titan Pharmaceuticals Price Quote

$7.09

Titan Pharmaceuticals Key Stats

Sell
39
Titan Pharmaceuticals (TTNP) is a Sell
Day range:
$6.75 - $8.00
52-week range:
$5.00 - $16.60
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.98%
Volume:
10.6K
Avg. volume:
11.5K
1-year change:
-55.35%
Market cap:
$6.5M
Revenue:
$1K
EPS:
$-7.41

How Much Does Titan Pharmaceuticals Make?

Data Unavailable

Is Titan Pharmaceuticals Growing As A Company?

Data Unavailable

Titan Pharmaceuticals Stock Price Performance

What Is Titan Pharmaceuticals 52-Week High & Low?

Titan Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Titan Pharmaceuticals?

Is Titan Pharmaceuticals Cash Flow Positive?

  • What Is TTNP Cash Flow From Operations?
    Cash flow from operations (TTM) is -$7.1M
  • What Is Titan Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $10M
  • What Is Titan Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Titan Pharmaceuticals Return On Invested Capital

Data Unavailable

Titan Pharmaceuticals Earnings Date & Stock Price

Titan Pharmaceuticals Competitors

  • Who Are Titan Pharmaceuticals's Competitors?
    Below is a list of companies who compete with Titan Pharmaceuticals or are related in some way:
    • AIM ImmunoTech Inc (AIM)
    • Allurion Technologies Inc (ALUR)
    • Armata Pharmaceuticals Inc (ARMP)
    • Outset Medical Inc (OM)
    • Protalix BioTherapeutics Inc (PLX)

Titan Pharmaceuticals Dividend Yield

Data Unavailable

Titan Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 14.29%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 140.00
Upside from Last Price: 1874.61%

Major Shareholders

  • How many TTNP shares are owned by institutional investors?
    1.1M TTNP shares are owned by institutional investors
  • How many TTNP shares are owned by insiders?
    0 TTNP shares are owned by insiders